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Background:  The ubiquitous pyruvate dehydrogenase multienzyme complex is
built around an octahedral or icosahedral core of dihydrolipoamide
acetyltransferase (E2) chains, to which multiple copies of pyruvate decarboxylase
(E1) and dihydrolipoamide dehydrogenase (E3) bind tightly but non-covalently.
E2 is a flexible multidomain protein that mediates interactions with E1 and E3
through a remarkably small binding domain (E2BD).
Results:  In the Bacillus stearothermophilus complex, the E2 core is an icosahedral
assembly of 60 E2 chains. The crystal structure of the E3 dimer (101 kDa)
complexed with E2BD (4 kDa) has been solved to 2.6 Å resolution.  Interactions
between E3 and E2BD are dominated by an electrostatic zipper formed by Arg135
and Arg139 in the N-terminal helix of E2BD and Asp344 and Glu431 of one of the
monomers of E3. E2BD interacts with both E3 monomers, but the binding site is
located close to the twofold axis. Thus, in agreement with earlier biochemical results,
it is impossible for two molecules of E2BD to bind simultaneously to one E3 dimer.
Conclusions:  Combining this new structure for the E3–E2BD complex with
previously determined structures of the E2 catalytic domain and the E2 lipoyl
domain creates a model of the E2 core showing how the lipoyl domain can move
between the active sites of E2 and E3 in the multienzyme complex.
Introduction
The 2-oxoacid dehydrogenases are a family of very large
multienzyme complexes consisting of multiple copies of at
least three enzymes which catalyze the oxidative decar-
boxylation of several different 2-oxoacids [1–5]. Members
of this family include pyruvate dehydrogenase (PDH),
2-oxoglutarate dehydrogenase (OGDH) and branched-
chain 2-oxoacid dehydrogenase (BCDH). The three
enzymes assembling to form these complexes are the
decarboxylase E1 (called E1p, E1o and E1b in PDH,
OGDH and BCDH, respectively), dihydrolipoamide
acetyl, succinyl and branched-chain transferase E2 (E2p,
E2o and E2b, respectively) and dihydrolipoamide de-
hydrogenase E3. The E3 component is identical in all three
complexes (PDH, OGDH and BCDH) and catalyzes the
same reaction. An exception occurs in Pseudomonas putida
[6], in which multiple genes code for three different dihy-
drolipoamide dehydrogenases. The structural core of all
2-oxoacid dehydrogenase complexes is formed of multiple
copies of E2 subunits, with the E1 and E3 subunits bound
on the periphery. 
The PDH multienzyme complex, acting at the end of the
glycolytic pathway, catalyzes the oxidative decarboxylation
of pyruvate, making acetyl coenzyme A (CoA) available for
the tricarboxylic acid cycle and other metabolic pathways.
The composition of the E2 core of the PDH complex is
such that, depending on the species, either 24 dihydro-
lipoamide acetyltransferase (E2p) chains are arranged in
octahedral symmetry or 60 E2p chains are arranged in
icosahedral symmetry [1,4,5,7,8]. 
The E2p subunit possesses a highly segmented structure
consisting of three independently folded domains
[4,8–11]. Depending on the species, one, two or three
lipoyl domains of about 80 residues are found at the N ter-
minus. Each lipoyl domain carries a lipoic acid molecule
covalently linked to a lysine residue. The lipoyl domain is
followed by a binding domain (E2BD), responsible for
binding E3 in the octahedral complexes, and for binding
both E3 and E1p in the icosahedral complexes [12,13].
The binding domain consists of about 35 residues, and is
one of the smallest globular domains known that lacks
disulfide bridges or prosthetic groups. The third domain is
the C-terminal (acetyltransferase) catalytic domain con-
sisting of about 250 residues. It forms the inner core of the
multienzyme complex and is also responsible for binding
E1p in the octahedral complexes. These three domains
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are connected to each other by long and highly flexible
linker regions, thereby allowing the lipoyl moiety to ‘visit’
all three active sites during catalysis [14–19].
The Bacillus stearothermophilus PDH multienzyme
complex has an icosahedral core of 60 E2p subunits [20]
surrounded by approximately 30 E1p a2b2 tetramers and
six E3 dimers, giving rise to a complex as large as 9 MDa.
In the B. stearothermophilus E2p chain only one lipoyl
domain, approximately 80 residues long, is found linked to
the 35-residue binding domain through a region of highly
flexible polypeptide chain consisting of about 50 residues
rich in alanine, proline and charged amino acids.
Several three-dimensional structures of components of the
multienzyme complexes have been solved so far. These
include X-ray structures of E3 from Azotobacter vinelandii,
P. putida, Pseudomonas fluorescens [21–23] and B. stearother-
mophilus (SSM, SS, JH, MDA, RNP and WGJH, unpub-
lished data). Even though the structure of an intact E2
subunit comprising all three domains is not known, struc-
tures of each of the individual domains have been solved.
Thus, the X-ray structure of the catalytic domain of
A. vinelandii E2 has been elucidated [5,24,25] and NMR
techniques have been used to solve the structures of 
lipoyl domains from B. stearothermophilus PDH [26] and
Escherichia coli PDH [27] and binding domains from
B. stearothermophilus PDH [28] and E. coli OGDH [29].
Biochemical studies have shown that the B. stearothermo-
philus E2BD (~35 residues) as well as a di-domain (E2DD;
~170 residues comprising the lipoyl domain linked to the
E2BD by the natural flexible linker) bind tightly to 
the B. stearothermophilus E3 dimer at a molar ratio of 1:1 
(i.e. one E3 dimer binds to only one E2BD or E2DD)
[30]. A similar ratio has been reported for the A. vinelandii
E3–E2BD complex [31]. This paper describes the crystal
structures of B. stearothermophilus E3 complexed with
E2BD (E3–E2BD) and with E2DD (E3–E2DD), thereby
allowing us to identify the crucial interactions for the
recognition of E3 by the binding domain. However,
because no residues of the lipoyl domain of E2DD could
be located in the electron-density maps, and the structures
of both E3–E2BD and E3–E2DD are very similar, we
refer to the E3–E2DD complex also as the E3–E2‘BD’
complex in this paper.
Results and discussion
Quality of the structure
The current atomic model includes 910 residues of the E3
dimer, two non-covalently bound FAD molecules and 41
residues of the di-domain corresponding to the binding
domain (Fig. 1). Six N-terminal residues of both
monomers of E3 are disordered and the nine C-terminal
residues, having very high temperature factors, could not
be modeled properly in both monomers. In addition, a
large N-terminal portion of the di-domain, corresponding
to the lipoyl domain and the flexible linker, appears to be
disordered in the crystal. Out of 951 residues, 88% fall in
the most favoured regions in the Ramachandran plot [32],
as revealed by the program PROCHECK [33].
Overall structure of B. stearothermophilus
dihydrolipoamide dehydrogenase (E3) 
E3 is a homodimeric flavoenzyme. Like other members of
the disulfide oxidoreductase family of known structure
(namely, glutathione reductase [34,35], thioredoxin reduc-
tase [36], trypanothione reductase [37] and mercuric
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Figure 1
Stereoview of the Ca tracing of the complex
of the B. stearothermophilus E3 dimer and
the E2 binding domain. The components are
shown in different colours: monomer A of E3
(blue); monomer B of E3 (red); E2 binding
domain (green) and FAD molecules bound to
E3 (yellow). (Drawn using MOLSCRIPT [49].)
reductase [38]), each monomer consists of four domains.
In the E3 monomer these are the FAD-binding, NAD-
binding, central and interface domains. Interactions
between monomers A and B of the E3 dimer are formed
largely by the interface domains. 
The structure of the uncomplexed E3 from B. stearother-
mophilus has been determined in our laboratory and will be
reported elsewhere (SSM, SS, JH, MDA, RNP and
WGJH, unpublished data). In order to explore the possi-
bility of structural changes accompanying the formation of
the E3–E2BD complex, the dimers of E3 in the uncom-
plexed and complexed structures were superimposed.
The root mean square (rms) deviation between the two
structures for all 910 Ca atoms is 0.8 Å. Thus, the overall
structure of E3 in the present complex is very similar to
that of uncomplexed E3.
Overall structure of the E2 binding domain (E2BD)
The three-dimensional solution structure of the uncom-
plexed E2BD from B. stearothermophilus, comprising
residues 128–170, has been determined by NMR spec-
troscopy [28]. In agreement with the NMR results, our
crystal structure also shows that the E2BD has a compact
structure consisting of two short a-helices comprising
residues 132–141 (H1) and 159–167 (H2), a distorted short
310-helix consisting of residues 145–147, and loops L1
(residues 142–144) and L2 (residues 148–158) joining these
structural elements. Hence, the overall structure of the
binding domain in the E3–E2BD complex is very similar to
that of the uncomplexed domain [28]. Both E3 and E2BD
appear to undergo little overall conformational change
upon complex formation, implying that recognition occurs
by a ‘lock and key’ rather than an ‘induced fit’ mechanism.
The two helices H1 and H2 of the E2BD pack against
each other with extensive hydrophobic interactions
involving residues Val134 and Tyr137 of helix H1 and
Ile162, Phe165 and Leu166 of helix H2. Val143 of the
loop L1 and the aliphatic part of Lys141 also participate in
this cluster of hydrophobic residues. These interactions
are illustrated in Figure 2. In addition, loops L1 and L2
joining the helices enclose a second hydrophobic core
involving residues Val143 from loop L1, Val148 and
Val157 from loop L2 and residues Ala138 from helix H1
and Ile162 from helix H2 (Fig. 2). Val143, located on loop
L1, makes hydrophobic interactions with residues of all
three helices, that is with Lys141 of helix H1, with
residues Ile162, Phe165 and Leu166 of helix H2, and with
Val148 which is located at the very beginning of loop L2.
In addition to these hydrophobic interactions, a few
hydrogen bonds contribute to the stability. These include
hydrogen bonds between Tyr137 OH and Asp163 Od1
(2.7 Å), Gln149 Ne2 and Thr151 Og1 (2.8 Å), Asn154 Od1
and Arg156 Nh1 (2.8 Å) and between Arg135 Nh1 and the
carbonyl oxygen of Ala130 (3.2 Å). Thus, the compact
structure of the binding domain is stabilized mainly by
hydrophobic interactions. 
In order to examine the conformational differences
between E2BD in the present crystal structure of the
complex and in the uncomplexed state determined by
NMR, the present E2BD structure was superimposed on
the NMR model. The rms deviation between the well-
defined Ca atoms of the present crystal structure and the
NMR structure (i.e. excluding loop L2) is 1.1 Å. The rela-
tive orientation of the two helices H1 and H2 in the com-
plexed and uncomplexed structures differs by only 2°.
However, loop L2 joining helix H2 and the 310-helix
adopts different conformations (Fig. 3). The tip of the loop
moves by 9.2 Å in the complex. This may be due to
changes taking place in loop L2 upon binding to E2 or,
alternatively, may reflect the intrinsic flexibility of loop L2.
It should be mentioned here that the average temperature
factors for all protein atoms of E3 as well as of E2BD are
higher than the values normally observed in proteins.
Although the average B-factor for the E2BD is 80 Å2, the
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Figure 2
Stereoview of the hydrophobic interactions
within the B. stearothermophilus E2 binding
domain. The compact structure of the binding
domain, comprising residues 130–170, is
stabilized mainly by hydrophobic interactions
(see text). (Drawn using MOLSCRIPT [49].)
electron-density maps show the geometry of the complete
E2BD clearly, including loop L2. Thus, the overall
structure of the binding domain in the complex is virtually
identical to that of the uncomplexed domain. The very
high temperature factor is most likely due to an overall
high thermal motion of all protein components in the
crystals (reflected by the high average thermal parameters
of 45 Å2 for E3 [Table 1]), coupled with an additional
flexibility, or possibly lower occupancy, of the binding
domain in the crystals. The relatively low resolution of the
data prevents a detailed investigation of these possibilities.
Interactions of the binding domain with E3
In our crystals, one E2BD is associated with one E3 dimer
(Fig. 4a). This is in good agreement with the maximal
binding ratio observed in biochemical studies [30]. The
E2BD is located close to the twofold axis of the E3 dimer
near the interface domain. In total, 1457 Å2 of surface are
buried upon complex formation between E3 and E2BD.
Roughly equal contributions to this buried surface area are
made by polar (721 Å2) and non-polar (736 Å2) residues.
In order to investigate why a second binding domain
cannot bind to the E3 dimer, a twofold-related binding
domain was generated using the E3 twofold axis. In this
hypothetical complex, loop L2 of E2BD clashes with the
same loop of the hypothetical symmetry-related E2BD
(Fig. 4b), thus accounting for the binding of a single
E2BD per E3 dimer. 
Because the role of the binding domain is to attach E3 to
the icosahedral core of the multienzyme complex,
complex formation between E3 and E2BD is not expected
to affect the active site of E3. The shortest distances
between the flavin rings belonging to the FAD cofactor
bound to E3 monomers A and B and the Ca atoms of the
E2BD are 31 Å and 21 Å, respectively (see also Fig. 4a).
Thus, as expected, the entrances to the E3 active sites
remain completely unblocked by the binding of E2BD.
Changes in the active site 
Although E2BD binds far away from the active site, some
changes in the active-site region of E3 are observed upon
complex formation. The side chains of the active-site
histidine, His446 and the nearby Glu451 of monomer B
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Figure 3
Stereo superposition of the
B. stearothermophilus E2 binding domain in
the complex structure (white) with the
uncomplexed NMR structure (grey). The
structures are very similar except for the
different conformations of loop L2. H1 and H2
indicate the two a-helices which are
composed of residues 133–141 and
160–168 respectively. The horizontal 310-helix
comprises residues 146–148. (Drawn using
MOLSCRIPT [49].)
Table 1
Crystal parameters, data collection and refinement statistics.
E3–E2BD E3–E2DD*
Crystallization conditions 12% PEG 600 12% PEG 600
200 mM ZnAc 200 mM ZnAc
pH 5.3 pH 4.9
Space group P3121 P3121
Cell dimensions (Å) a=106.7, c=204.6 a=106.6, c=204.3
Resolution (Å) 3.1 2.6
VM (Å3 Da–1) 3.2 2.8
No. of unique reflections 26 033 44 969
Completeness of data (%)
Cumulative 87.9 95.0
Last shell 56.3 (3.08–3.02 Å) 88.3 (2.64–2.95 Å)
Rmerge (%)† 6.3 9.2
No. of unique reflections used‡ – 39 195
Resolution range (Å) – 8.0–2.6
Rms deviations in
Bond lengths (Å) – 0.01
Bond angles (°) – 1.5
Improper dihedrals (°) – 1.3
Proper dihedrals (°) – 24.9
R-factor (%) – 21.5
Mean B value (Å2)§
E3 monomer A – 46
E3 monomer B – 45
BD – 80
No. of water molecules – 37
*Because these data only revealed the binding domain, and not the lipoyl
domain, this data set is also referred to as E3–E2‘BD’.
†Rmerge=S|I–〈I〉|/ SI〈I〉. ‡Only reflections with F>2s(F) were used in
refinement. §For all protein atoms. 
(hereafter referred to as HisB446 and GluB451) have com-
pletely different geometries in the present structure com-
pared with the uncomplexed E3 structure. In monomer A,
on the other hand, both of these residues adopt the same
conformations as in the uncomplexed B. stearothermophilus
E3. In spite of the differences in the side-chain geometries
of these two residues in the two monomers, they still
maintain a hydrogen bond between them. This hydrogen
bond fixes the conformation of the imidazole ring of
His446 close to the disulfide bond between Cys47 and
Cys52, but only in monomer A. The Ne2 atom of HisA446
is 3.8 Å away from the Sg atom of CysB47, which compares
with a value of 3.3 Å in the uncomplexed E3. However,
the new position of HisB446 places its Ne2 atom 5.8 Å
away from the Sg atom of CysA47. HisB446 in the present
conformation in fact makes a strong bifurcated hydrogen
bond with HisA323 as well as with GluB451. In view of the
large distance between the binding domain and the active
site, and the overall similarity of complexed and uncom-
plexed E3, it is unlikely that these active-site differences
are induced by the interactions with the binding domain.
Rather, these differences may reflect intrinsic flexibility in
the active site of dihydrolipoamide dehydrogenase.
Nature of the E3–BD interface
The E3–E2‘BD’ complex is stabilized almost entirely by
electrostatic interactions between the binding domain and
residues from the interface domain of both E3 monomers
(Table 2). Most of the residues of E2BD which participate
in forming salt bridges with E3 are from helix H1. Helix
H2 does not interact with E3. While Ser133 and Lys136 of
the E2BD (BDSer133 and BDLys136) make interactions
with monomer A of E3, BDArg135, BDArg139 and
BDArg156 interact with monomer B of E3. The hydrogen
bond between the side chain of BDArg135 and the main-
chain carbonyl oxygen of residue BDAla130 helps to main-
tain the side chain of BDArg135 in a favourable position
for interaction with GluB431 and AspB344. BDArg135
assumes different side-chain torsion angles, in particular x1
and x4, compared with those in the uncomplexed E2BD
structure. BDArg135 and BDArg139 form an electrostatic
zipper with AspB344 and GluB431 (Fig. 5). Residues
AspB344 and GluB431 adopt different side-chain geome-
tries in the complex structure compared with uncomplexed
E3 (SSM, SS, JH, MDA, RNP and WGJH, unpublished
data) in order to facilitate the formation of salt bridges with
the binding domain (Fig. 5). The x1 and x2 values for
AspB344 are –170° and –168°, respectively, in the complex
structure, compared with 49° and –147°, respectively, in
the uncomplexed E3 structure. Similarly, the side-chain
torsion angles x1, x2 and x3 for Glu B431 are –160°, 64°
and 41° in the structure of the complex compared with
–87°, –79° and –21° in the uncomplexed E3 structure. 
As discussed above, loop L2 of the E2BD adopts a differ-
ent conformation upon binding to E3. The hydrogen bond
between the side chains of residues BDAsn154 and
BDArg156 helps position the side chain of BDArg156
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Figure 4
Stereoview of the B. stearothermophilus
E3–E2BD complex. The four domains of each
monomer of E3 are shown in different colours:
yellow, FAD-binding domain (residues
7–147); green, NAD-binding domain
(residues 148–276); red, central domain
(residues 277–345) and magenta, interface
domain (residues 346–461). The FAD
cofactors are shown in ball-and-stick
representation in each E3 monomer. (a) One
E2BD (blue) is shown bound to one E3 dimer,
as observed in the crystal structure. (b) A
hypothetical model showing one E3 dimer
with two E2 binding domains bound, related
by the E3 dimer axis. Note the severe steric
clash between the twofold-generated E2BD
(purple) and the E2BD in the crystal structure
(blue). (Drawn using MOLSCRIPT [49].)
within hydrogen-bonding distance of the carbonyl oxygen
of residue AlaB432. This new geometry of the loop after
complex formation is stabilized by only one hydrogen
bond between the side chain of Arg156 and the main
chain of E3 (AlaB432). The overall view is that virtually all
interactions are electrostatic (as suggested by Robien et al.
[29]), with rather small side-chain movements required for
positioning the charged interface side chains of E3 and
E2BD optimally with respect to each other.
Conservation of electrostatic interface
An alignment of all known binding-domain sequences
(Fig. 6) shows that a number of residues are conserved in
most of the binding domains. Pro132 occurs at the begin-
ning of helix H1, acts as a helix promoter and is conserved
in all binding domains, except yeast E2o. Gly142, which is
conserved in the E2p subfamily (Fig. 6), has a left-handed
conformation with (f,c) values of (58°,35°). While most of
the binding-domain sequences have a glycine in this posi-
tion, others have asparagine or alanine. Asparagine is
known to favour this geometry [39]. Gly152 and Gly155
are conserved in virtually all the binding-domain
sequences. This conservation is due to their special posi-
tion in the Ramachandran map [32] with (f,c) values of
(85°,–137)° and (101°,21°) respectively. Thus, replacing
these two residues by non-glycine residues would be con-
formationally unfavourable. The hydrophobic residues
143, 148, 157 and 162, which are conserved in all binding-
domain sequences (Fig. 6), are essential for the formation
of a hydrophobic core within the binding domain. Ala138,
which is conserved in almost all binding domains, also par-
ticipates in forming this hydrophobic core. Therefore the
conserved residues Pro132, Ala138, Gly142, Val143,
Val148, Gly152, Gly155, Val157 and Ile162, are likely to
play important roles in the compactly folded binding
domain throughout the multienzyme complex family.
Interestingly, BDArg156, which is involved in the electro-
static zipper between E3 and E2BD, and it flanking
residues, BDGly155 and BDVal157, are conserved in
almost all binding domains (Fig. 6). As mentioned earlier,
BDGly155 has a structural role, while BDVal157 contributes
to the hydrophobic core within the E2BD and BDArg156
helps to maintain the loop geometry in close proximity to
E3. Thus, the tripeptide Gly155-Arg156-Val157 of the
E2BD appears to be important not only for the stability,
but also for the function of the binding domain.
A sequence alignment of E3 (not shown) indicates that
out of the four residues that interact with the binding
domain in B. stearothermophilus E2p, three, namely
Glu431, Glu437 and Asp438, are conserved in almost all
E3 sequences, whereas Asp344 is less well conserved.
Thus, residues involved in the electrostatic zipper shown
in Figure 5 are generally conserved both in E3 and in the
E2 binding domain in the three 2-oxoacid dehydrogenase
multienzyme complexes.
As BDArg135 and Glu431 of E3 are conserved in most of
the binding domains and E3s respectively, these two
residues appear to be crucial in the recognition process for
complex formation (Fig. 5). Residue 156 on loop L2,
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Figure 5
Electrostatic zipper between E3 (green, monomer A; pink, monomer B)
and E2BD (blue) of B. stearothermophilus. The side chains of Asp344
and Glu431 of monomer B of E3 adopt different conformations in the
present complex structure to facilitate the formation of salt bridges with
the binding domain. Side chains of Asp344 and Glu431 in the
uncomplexed E3 structure are shown with thin bonds. (Figure drawn
using RASTER3D [50,51].)
Table 2
Interactions between E3 and binding domain.
E2BD E3* Distance (Å)
Polar Ser133 Og GluA437 Oe1 2.8
Ser133 N AspA438 Od1 2.9
Arg135 Ne AspB344 Od2 3.1
Arg135 Nh1 GluB431 O 2.9
Arg135 Nh2 GluB431 Oe2 2.8
Lys136 Nz GluA437 Oe2 3.2
Arg139 Nh2 AspB344 Od1 3.5
Arg156 Nh2 AlaB432 O 2.5
Apolar Met131 Cb AspA438 Cg 3.8
Pro132 C LeuA441 Cd1 3.8
Pro132 Cb LeuA441 Cb 3.7
Pro132 Cg GluB431 Cg 3.6
Ser133 Cb AspA438 Cg 3.6
Arg139 Cd AlaA342 Cb 3.8
Arg139 Cz AlaB342 Cb 3.7
Glu140 Ca ProB334 Cg 3.6
*A or B before the residue number indicates whether it belongs to
monomer A or monomer B.
which is an arginine in all but one of the binding domains
listed in Figure 6, is crucial for maintaining the loop in the
conformation observed in the E3–E2BD complex. Hence,
the key residues of E2BD and E3 observed to be interact-
ing with each other in the B. stearothermophilus structure
appear to be well conserved throughout the ‘p’, ‘o’ and ‘b’
subfamilies of all 2-oxoacid dehydrogenase multienzyme
complexes. It is intriguing that this is the case irrespective
of whether E2 forms an icosahedral or an octahedral core. 
Helix H2 of E2BD, comprising residues 159–167, does not
interact with E3, but may be involved in binding E1.
Gly150 of loop L2 is conserved in all pyruvate and
branched-chain dehydrogenase binding-domain sequences.
As pointed out by Kalia et al. [28] from their NMR struc-
ture of the isolated binding domain, any side chain in this
position would project out into the solvent region and
could interfere with the recognition of E3 or E1. From the
present crystal structure of the complex, it is clear that this
residue does not interact with E3. Thus, Gly150 may be
important in binding to E1 and its replacement by a larger
residue might result in steric clashes with E1. Residue
159, which is solvent exposed, is either a lysine or an argi-
nine in the majority of binding-domain sequences and
could be involved in electrostatic interactions with E1.
PDH multienzyme complex in B. stearothermophilus
The B. stearothermophilus PDH is a non-covalently bound
multienzyme complex consisting of a large icosahedral core
of sixty E2p subunits surrounded by six E3 dimers and
thirty E1p tetramers [20]. From the present crystal struc-
ture of the E3–E2‘BD’ complex we have modeled six E3
dimers complexed with six binding domains. Plausible
positions of these E3 dimers with respect to the icosa-
hedral E2 core are shown in Figure 7. Flexible linkers were
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Figure 6
Sequence alignment of all known binding
domains as calculated by the GCG package
[47]. Key to sequence origins: Odp2, pyruvate
dehydrogenase (PDH); Odo2, 2-oxoglutarate
dehydrogenase (OGDH); Odb2, branched-
chain 2-oxoacid dehydrogenase (BCDH);
Bacst, Bacillus stearothermophilus; Azovi,
Azotobacter vinelandii; Ecoli, Escherichia coli;
Bacsu, Bacillus subtilis; Achla, Acholeplasma
leidlawii; Neucr, Neurospora crassa; Dicdi,
Dictyostelium discoideum; Psepu,
Pseudomonas putida. Boxed residues are: a,
structurally conserved; b, form hydrophobic
core within BD; c, involved in binding E3; d,
possibly involved in binding to E1.
Figure 7
Model of the dihydrolipoamide dehydrogenase (E3) and dihydrolipoamide
acetyltransferase (E2) components in the pyruvate dehydrogenase
multienzyme complex of B. stearothermophilus. The icosahedral core
(magenta) consists of 60 E2 catalytic domains. Six E3 dimers (yellow) are
bound to the periphery of the core with the help of the binding domains
(BD, red). The binding domain is connected to the lipoyl domain (LD,
green) as well as the catalytic domain by flexible linkers. The lipoyl group,
which is covalently attached to the lysine at position 42 (red dot) of LD,
swings from position 1 to 2 to 3 in order to visit the active site of E2.
Similarly, the movement of LD from position 4 to 5 to 6 in order to reach
the active site of E3 is also illustrated. Going from 1 to 6, the motion of the
LD is as in a ‘movie’, showing the delivery of an acetyl group to the active
site of E2 followed by disulfide bridge reduction in the active site of E3.
modeled between the E2 catalytic domain [5] and the
binding domain as well as between the binding domain
and the lipoyl domain [26]. Figure 7 illustrates how the
lipoyl domain can visit the active sites of both E2 and E3. 
Biological implications
In virtually all living organisms three very large
multienzyme complexes exist which are responsible
for transferring different acyl groups to the sulfhydryl
of coenzyme A. These three complexes are the pyru-
vate dehydrogenase (PDH), the 2-oxoglutarate dehy-
drogenase and the branched-chain 2-oxoacid
dehydrogenase complexes. In the PDH complex the
first enzyme is pyruvate dehydrogenase, or E1. The
second enzyme is dihydrolipoamide acetyltrans-
ferase, or E2, which contains a covalently bound
lipoyl function that transfers the acetyl group to
coenzyme A. The third enzyme is the dihy-
drolipoamide dehydrogenase, or E3. One of the most
striking variations within this family of complexes
concerns the transferase (E2), which can assemble to
form either an octahedral or an icosahedral core. In
the PDH complex of Bacillus stearothermophilus the
E2 core is icosahedral. Each E2 polypeptide consists
of three domains: an 80-residue lipoyl domain, a
small 35-residue ‘binding domain’ and the 250-residue
catalytic domain. These domains are linked by flexi-
ble segments of polypeptide chain up to 50 residues
long. The binding domain binds E1 or E3, but not
both simultaneously. The flexible linker allows the
binding domain (associated with either E1 or E3) to
move quite freely with respect to the core formed by
the E2 catalytic domains. The structures of E3 and
the cubic core of PDH have both been well charac-
terized. However, several questions remain such as
the manner in which E1 and E3 interact with the
binding domain of E2.
Our crystal structure of the complex formed between
the B. stearothermophilus E2 binding domain and E3
reveals the way in which the 4 kDa E2 binding
domain is associated with the 101 kDa dimeric E3. A
single E2 binding domain is found per E3 dimer, a
result of the close proximity of the site of attachment
of the binding domain to the molecular twofold axis of
E3. The interactions between the E2 binding domain
and E3 are all mediated by charged side chains,
forming an ‘electrostatic zipper’. These results are in
good agreement with earlier biochemical studies. The
residues of the binding domain involved in the interac-
tions are all provided by helix 1 of this domain, while
the residues from E3 interacting with the binding
domain are provided by both subunits of the E3 dimer.
Comparison of the known E2 and E3 sequences indi-
cates that this mode of interaction is likely to recur in
all three types of multienzyme complex.
Combining the new structural knowledge in this
paper with the earlier determined structures of the
E2 catalytic and lipoyl domains allows the construc-
tion of a model in which six E3 dimers are complexed
with the binding domains of the icosahedrally
arranged E2s. This allows the lipoyl domain to swing
round and ‘visit’ the active sites of E2 and E3 in the
multienzyme complex. This model shows how the
well-defined, highly symmetric, core of this remark-
able complex is surrounded by tremendous structural
flexibility of crucial functional significance.
Materials and methods
Crystallization and data collection
Crystals of both B. stearothermophilus E3 complexed with the E2BD
(residues 116–170 of E2p) and E3 complexed with E2DD (residues
1–170 of E2p) were obtained by the vapour diffusion technique at
room temperature using 10ml of a 9–10 mg ml–1 protein solution with
12% PEG 600 as precipitant in the presence of 200 mM zinc acetate
and 1 µM FAD. The best crystals of E3–E2BD were grown at pH 5.3,
whereas those for E3–E2DD were obtained at pH 4.9. Crystals were
mounted in capillaries in the presence of mother liquor which was
made up of 14% PEG 600, 200 mM zinc acetate, 1mM FAD and
100 mM sodium acetate (pH 5.3 and 4.9 for E3–E2BD and E3–E2DD
respectively). E3–E2BD crystals were more sensitive to X-rays than
E3–E2DD crystals. It has been shown earlier from biochemical studies
that the di-domain E2DD binds E3 more tightly than the binding
domain E2BD [30]. Data up to 3.1 Å resolution were collected for the
E3–E2BD complex on the R-axis imaging plate and processed using
R-axis software. In addition, better data for the E3–E2DD complex
were collected both on the in-house R-axis imaging plate and on beam-
line F1 at the Cornell High Energy Synchrotron Source (CHESS) using
image plates processed using DENZO [40] and scaled using
SCALEPACK [41]. The overall R-merge for the E3–E2DD data set up
to 2.6 Å resolution is 0.092 with a completeness of 95%. Crystal para-
meters and data collection statistics are given in Table 1. The crystals
contain one E3 dimer and one E2BD or E2DD monomer per asymmet-
ric unit with a VM of 3.2 Å3 Da–1. Because these E3–E2DD crystals do
not reveal the lipoyl domain but do show the binding domain we refer
to this complex also as E3–E2‘BD’ in this paper.
Structure determination and refinement
The molecular replacement method was used to solve the phase
problem for the E3–E2DD complex. The search model was the
B. stearothermophilus E3 dimer containing all protein and FAD atoms
with their individual temperature factors (SSM, SS, JH, MDA, RNP 
and WGJH, unpublished data). Structure factors for the model 
were calculated in an artificially large P1 unit cell of dimensions
150 Å×134 Å×117 Å and angles of 90°. Cross-rotation functions
were calculated using Crowther’s fast rotation function [42] adapted to
the CCP4 program suite [43], using data between 8.0 Å and 4.0 Å.
The results showed two peaks 9s above the mean. These two peaks
were related by a 180° rotation corresponding to the two different
superpositions of the dimers. The positional search was carried out
with the Crowther and Blow [44] T2 translation function using the
TFFC program in the CCP4 suite. Translation functions were calcu-
lated in the resolution range 10–3.5 Å. The translation function gave a
clear peak 45s above the mean. After correctly positioning the E3
dimer in the unit cell, an R-factor of 43.6% at 2.6 Å was obtained. The
same rotation and translation values were obtained independently for
the E3–E2BD complex.
The molecular replacement solution of E3 was the starting model for
refinement. Crystallographic refinement was carried out using X-PLOR
[45]. Rigid-body refinement was carried out first, keeping the entire E3
dimer as a rigid body and later allowing the two monomers to move
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independently. This decreased the R-factor to 36.0%. The positional
refinement, followed by B-factor refinement, was carried out by means of
X-PLOR’s energy minimization option. Simulated annealing refinement
was subsequently carried out with a gradual decrease of the tempera-
ture from 2000 K to 300 K. This was followed by positional and B-factor
refinement. Difference Fourier maps at this stage clearly showed a
cluster of densities 3s above the mean near the twofold axis of the
dimer. One helix of the E2BD could be fitted in part of the density.
Further energy minimization and B-factor refinement after including this
helix, however, did not generate improved maps. At this stage, various
mFo–nFc maps were calculated. Interestingly, a (1.1Fo–Fc) map showed
the second helix clearly. The relative orientation of the helices agreed
very well with the NMR model of the binding domain solved earlier [28].
However, the loop joining the two helices could not be modeled. Only
after further refinement and model building could the loop joining the
two helices be traced. Eventually the R-factor dropped to 21% (Table
1). The average B-factors for all protein atoms of both E3 and E2BD are
higher than values normally found in proteins (see Table 1). The temper-
ature factor for helix H1 of E2BD, which interacts with E3, is 67 Å2. This
contrasts with the value of 84 Å2 for helix H2 of E2BD, which is solvent-
exposed. The final 2Fo–Fc map showing the density for helix H1 and its
electrostatic interactions with the residues of E3 is illustrated in Figure 8.
The secondary structure elements of the binding domain were identified
using the program DSSP [46]. Buried accessible surfaces were calcu-
lated using the SURFACE program of the CCP4 suite [43]. Sequence
alignment was done using the GCG package [47]. Model building was
performed using the program O [48]. The quality of the model was
checked by plotting the Ramachandran map [32]. The geometry of the
final model was evaluated using the program PROCHECK [33].
The coordinates have been deposited in the Brookhaven Protein Data
Bank.
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